Usefulness of Glucagon-Like Peptide-1 Receptor Agonists to Reduce Adverse Cardiovascular Disease Events in Patients with Type 2 Diabetes Mellitus

Simran Grewal, Ninad Zaman, Louis Borgatta, Matthew Nudy, Andrew J. Foy, Brandon Peterson

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Usefulness of Glucagon-Like Peptide-1 Receptor Agonists to Reduce Adverse Cardiovascular Disease Events in Patients with Type 2 Diabetes Mellitus'. Together they form a unique fingerprint.

Medicine & Life Sciences